Aim immunotech rejects director nomination notice from activist group due to numerous material defects, omissions and false and misleading statements

Ocala, fla.--(business wire)--aim immunotech inc. (nyse american: aim) (“aim” or the “company”) today announced that, after careful deliberation, its board of directors (the “board”) unanimously concluded that the notice (the “notice”) submitted by ted d. kellner purporting to nominate himself, robert l. chioini and todd deutsch for election to the company's board at the 2023 annual meeting of stockholders (the “2023 annual meeting”) fails to comply with the company's bylaws (the “bylaws”) and.
AIM Ratings Summary
AIM Quant Ranking